Related Experiment Video
Updated: Aug 5, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β Is Critical for Ovarian Cancer Migration, Invasion, and Chemosensitivity
Christopher Elms1, Wei Wei2, Michael J Birrer1
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Cancers
|July 28, 2026
Summary
Targeting the TGF-β pathway with inhibitors like LY2157299 reduced ovarian cancer cell aggressiveness and enhanced cisplatin chemotherapy effectiveness. This suggests potential new treatments for patients with suboptimal surgical outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Standard ovarian cancer treatment involves surgery and chemotherapy, but suboptimal debulking remains a poor prognostic indicator.
- Transforming growth factor-beta (TGF-β) pathway activation is linked to ovarian cancers that are difficult to fully resect.
- Investigating TGF-β pathway's role in ovarian cancer biology is crucial for developing improved therapeutic strategies.
Purpose of the Study:
- To investigate the role of the TGF-β pathway in ovarian cancer cell behaviors.
- To evaluate the efficacy of TGF-β receptor 1 (TGFBR1) kinase inhibitor LY2157299 in vitro and in vivo.
- To assess the combined effects of TGF-β inhibition and chemotherapy.
Main Methods:
- Utilized the TGFBR1 kinase inhibitor LY2157299 to assess ovarian cancer cell adhesion, proliferation, migration, and invasion in vitro.
- Employed a TGF-β responsive reporter construct to elucidate pathway involvement in cellular interactions.
- Generated TGFBR1 and TGFBR2 CRISPR knockout ovarian cancer cells to examine growth and chemosensitivity in vivo.
Main Results:
- LY2157299 treatment inhibited TGF-β pathway, decreasing ovarian cancer cell migration, invasion, and adhesion to mesothelial cells.
- TGFBR1 and TGFBR2 knockout cells exhibited reduced proliferation, both at baseline and upon TGF-β or LY2157299 treatment.
- TGFBR2 knockout cells demonstrated enhanced sensitivity to cisplatin, leading to a significant reduction in tumor weight in vivo.
Conclusions:
- TGF-β pathway inhibition effectively targets cancer cell behaviors contributing to suboptimal debulking in ovarian cancer.
- Combined TGF-β inhibition and cisplatin showed an additive anti-tumor effect.
- While LY2157299 has solubility limitations, other TGF-β inhibitors represent promising therapeutic options for ovarian cancer.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...